AstraZeneca Education Hub: The Silent Threat: Exploring CKD Mortality Evidence in Type 2 Diabetes Population

Thursday, August 21, 2025
1:15 PM - 2:00 PM
Exhibition Hall - Theatrette 2

Speaker

Agenda Item Image
Dr Thomas Dover
Endocrinologist
Queensland Health

The Silent Threat: Exploring CKD Mortality Evidence in Type 2 Diabetes Population

Biography

Dr Thomas Dover MBBS (Hons 1) FRACP, BHSc (Dietetics: Hons), BAppSc (Exercise Science) Endocrinologist, Dietitian, Exercise Physiologist. Tom is the Director of Endocrinology at Ipswich hospital, works across the Mater hospital South Brisbane, Indigenous clinics in Ipswich, Bundaberg and Rockhampton, Heart of Australia (rural Qld) and private practice. Prior to medicine he completed degrees in exercise science, and nutrition and dietetics, working both as an exercise physiologist and dietitian in the community and public hospitals. Outside of medicine Tom is an avid long distance runner, having completed over 20 marathons.
Agenda Item Image
A/Prof Sree Venuthurupalli
Head of Renal Medicine
Ipswich Hospital

The Silent Threat: Exploring CKD Mortality Evidence in Type 2 Diabetes Population

Biography

Dr Venuthurupalli graduated from Andhra Medical College (MBBS with honors in social and preventative medicine). He then completed his MD in Internal Medicine and DM in Nephrology from the Postgraduate Institute of Medical Education and Research, a premier medical and research institution in Chandigarh, India. After completing his FRACP from the Royal Australasian College of Physicians in 2008, Dr Venuthurupalli has been working as a senior consultant with Queensland Health, and was formerly the director of renal services for one of the largest regional hospitals in South East Queensland. Dr Venuthurupalli is recently promoted as Associate professor with the University of Queensland, and he has completed his PhD on the Chronic Kidney Disease Queensland (CKD.QLD) Project with the University of Queensland- Centre for chronic disease.
loading